power. Similar results emerged from Cuffel
analysis of substance misuse among 231 cases of schizophrenia identi fied in the Epidemiologic Catchment Area study. Substance misusems in this study did not differ from non-misusems in age at onset, treatment history or the prevalence of psychotic symptoms.
In the face of these conflicting results it is difficult to decide upon the nature of the relationship, if any, between cannabis use and the age at onset, premorbid personal ity, or the pmevalence of psychotic symp toms in people with schizophrenia. None of this exculpates cannabis use from being a possible risk factor for psychosis, or its continued use as a behaviour that may exacerbate the course of schizophrenia.
Cuffel, B.J., H.ithoff, K A. a @ (1993) Correlatesof patternsof substanceabuseamongpatients with schizophrenia. Hospital and CommunityPsychiatry. 44. 247â€"251. Hambr.cht, N. a Heftier, H. (1996) Substanceabuseand the onsetofschizophrenia.Biological Psychiatry, 40. I 55-I163.
Kovasznay,B., Bromet, E., Schwartz, J. B., at at ($993) Substanceabuseand onsetof psychoticillness. Hospital and CommunityPsychiatry. 44, 567â€"571. employing a GP researcher who would have been able to interpret the sometimes arcane way in which material is entered. Despite that, however, to recommend that there should be a standardised method for recording consultations in primary care is extraordinary. This shows a total lack of appreciation of the problems facing GPs. What is needed is hinted at later in the paper, where it is suggested that commu nity psychiatric nurses (CPNs) should be involved. Our own practice is now under taking a review of all patients by our locality attached CPN as a pilot to under taking the same work throughout the six practices in our small locality. The aim of this review is to enter in the notes a care plan for each patient, with clear indications as to who the keywomkemwill be.
My other concern is that Lang et a! fail to recognise a further major problem in primary care. At present, notes are kept separately by health visitors and by nurses in the majority of practices, with the result that themeis no comprehensive primary care record. In the case of people with schizo phrenia this can mean that contact for depot injections is undertaken by a nurse and recorded separately. In some casesthe family will be supported by a health visitor, and again separate records may be kept.
This fragmentation, which is part of the inheritance of a divided primary care service, needs to be tackled along with developing seamless care for this group of patients. Lang et al's central finding that problem patients have a past history of drug misuse is, however, an important and helpful finding, although it is not clear whether this includes alcohol remaining as one of the problem areas in older patients with schizophrenia. Author's reply: Dr Simpson is mightto draw attention to lack of contact which many people suffering from schizophrenia have with the local psychiatric services. In the companion paper to the one Dr Simpson comments upon (Lang et a!, 1997) we clearly define our study populations. The 193 patients whom we studied had all had at least one admission to the Royal Edinburgh Depressive delusions and the general election Sir: I would like to report the caseof an 80-year-old man, with no previous psychiatric or significant medical history, who six days after the landslide general election defeat of the Conservative Party developed depres sive delusions that because of the Labour victory his investments were now worthless and his business was going to fail leaving him and his family penniless and forcing him to sell his house. He was agitated and extremely distressed by these ideas and believed his wife and adult daughter should kill themselves to avoid the shame of penury. He was in clear consciousness with no cognitive impairment. Mild symptoms of depression had started two weeks before with loss of energy and interests and sleep disturbance; these were treated with fluox etine, to which he had shown no response. He was admitted to hospital but became acutely confused. Investigations showed hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secre tion, probably secondary to the fluoxetine. is marred by a number of features. First, the sample data are not clearly defined. It would appear that the 193 patients who took part in the study were psychiatric out patients. A recent review in my own practice found that more than one-third of those with schizophrenia were not known to the local psychiatric services.
Second, the difficulties in reviewing the entries in the case notes, although under standable, should have been dealt with by
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Hospital in the five years prior to the study commencing. Less than half (49%) of our study sample were in regular contact with a psychiatrist (see Lang et a!, 1997, Table 1 ).
We would agree with Dr Simpson that the development of a comprehensive pri mary came record for patients with schizo phrenia would be a welcome advance. We are of the opinion, however, that if people other than GPs are to contribute to such records, it is essential that a standardised method of recording consultations in the primary care setting is devised.
We agree with Dr Simpson that alcohol misuse in both younger and older people with schizophrenia significantly contributes to the difficulties which arise in patient management, but we did not find that a past history of alcohol misuse was mdc pendently related to whether or not a patient was considered by the GP as causing a problem for the practice.
Lang, F. H. Forbes, j. F., Murray, G. D@, at at (1997) Service provision for peoplewith schizophrenia: I. clinical and economicperspective.BritishJournalof Psychiatry, IlL l59â€" 64.
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Lethal lithium poisoning with sustained-release preparations Sir: Cookson (1997) and Moncreif (1997) have mentioned serious toxicity and death as a consequence of lithium intoxication. It would be useful to stress that more serious poisoning usually occurs after intoxication by sustained-release lithium preparations.
In 27 years of lithium medication in Southern Moravia, four cases of lethal intoxication have been reported, three of them suicides. All three patients took a high dose of the sustained-release lithium pro duct. In two cases, the approximate doses were known (SO and 70 g lithium). In one case, the dose has not been established. Two of the patients died on the fifth day and the other died on the 12th day after taking the lethal dose of lithium. In one of the patients, the autopsy revealed undis solved lithium tablets in the stomach and the remains of tablets in the intestines, despite a gastric lavage. In another patient, high levels of lithium (34 and 11.3 mmol/l, respectively) were found in the gastric lavage returns on the first and second days.
It seems that the advantage of sus tamed-release preparations becomes a dis advantage during intoxication. Standard gastric lavage does not remove the lithium tablets from the gastro-intestinal tract, and if they are not removed, lithium is released for a surprisingly long period of time.
One effective method, proposed by Smith et a! (1991 ) , is gastric lavage with polyethyleneglycol, which can prevent the absorption of up to 67% of the ingested lithium. Other authors recommend gastro scopy combined with aspiration, under visual control, or enterotomy to remove the tablets in addition to lavage (Olson, 
M. Hrdli&a Department ofPsychiatry, 2nd
MedicalSchoolof Charles University,V @valu 84, 150 18Prague, Czech Republic
p. @ev@Ik Department ofAnaesthesiology, Medical
Schoolof Masaryk University,Brno,Czech Republic Tardive dyskinesia and CYP2D6 polymorphism in Chinese Sir: Epidemiologicalstudieshave shown a lower prevalence rate of tardive dyskinesia among Chinese than Caucasian subjects receiving neuroleptics (Swartz et a!, 1997) . A pharmacogenetic factor may underlie this cross-cultural difference. The study by Arm strong et a! (1 997) which suggests an association of neuroleptic-induced move ment disorders, including tardive dyskinesia, with genetic polymorphism of CYP2D6 supports this hypothesis. About 7% of the Caucasian population lacks the CYP2D6 enzyme (i.e. poor metabolisers) compared with about 1% of the Chinese (Bmosen, 1996) . The majority of these Caucasian poor metabolisers have a mutant allele 2D6(B), which contains a splicing defect that is not present in a large section of the Chinese population (Brosen, 1996) . New mutations have recently been reported, including the C/ T2938variation that results in one amino acid difference (R296C). This mutation, postu lated to be in the putative substrate-recogni tion site of the CYP2D6 enzyme, also shows ethnic differences in its distributions (26% in Caucasians, 19% in Chinese) (Wang et a!, 1995) . It has also been reported to be associated with Parkinson's disease (Tsu neoka eta!, 1993) . This is intriguing because patients with a family history of Parkinson's disease have a high risk for developing tardive dyskinesia (Swartz et a!, 1997) . This suggests an association of a vulnerability to tardive dyskinesia with the R296C muta tion â€"¿ a possibility that merits further investigation.
